Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03827928 · ClinicalTrials.gov registry record · NA

LoveYourBrain Yoga for Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT03827928 is a NA study of Multiple Sclerosis that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 15 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03827928, a NA study of Multiple Sclerosis, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to assess the feasibility of a 6-week yoga and meditation intervention for people with multiple sclerosis (MS). The study will evaluate the impact of the program on fatigue, anxiety, depression, positive affect, and other measures. A sub-study will collect brain images using MRI on 2 subjects before and after the intervention to identify potential biological markers of MS related-fatigue.

Conditions Studied

Interventions

  • BEHAVIORAL Yoga/meditation

Study Locations (1)

New Hampshire

  • Dartmouth-Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2019-07-01
Est. Completion 2019-12-30
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT03827928

The ClinicalTrials.gov registry entry for NCT03827928 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Yoga/meditation is the first listed.

NCT03827928 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT03827928 about?

NCT03827928 is a clinical study titled "LoveYourBrain Yoga for Multiple Sclerosis". The purpose of the study is to assess the feasibility of a 6-week yoga and meditation intervention for people with multiple sclerosis (MS). The study will evaluate the impact of the program on fatigue, anxiety, depression, positive affect, and other measures. A sub-study will collect brain images us...

What is the current status of trial NCT03827928?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-07-01. Estimated completion is 2019-12-30.

What conditions does trial NCT03827928 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT03827928?

The interventions under investigation include: Yoga/meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03827928?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03827928 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.